Does RAVULIZUMAB-CWVZ Cause Haemolysis? 242 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 242 reports of Haemolysis have been filed in association with RAVULIZUMAB-CWVZ. This represents 2.4% of all adverse event reports for RAVULIZUMAB-CWVZ.
242
Reports of Haemolysis with RAVULIZUMAB-CWVZ
2.4%
of all RAVULIZUMAB-CWVZ reports
3
Deaths
66
Hospitalizations
How Dangerous Is Haemolysis From RAVULIZUMAB-CWVZ?
Of the 242 reports, 3 (1.2%) resulted in death, 66 (27.3%) required hospitalization, and 4 (1.7%) were considered life-threatening.
Is Haemolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAVULIZUMAB-CWVZ. However, 242 reports have been filed with the FAERS database.
What Other Side Effects Does RAVULIZUMAB-CWVZ Cause?
Fatigue (1,472)
Asthenia (727)
Headache (639)
Drug ineffective (570)
Off label use (451)
Muscular weakness (422)
Dyspnoea (414)
Malaise (353)
Haemoglobin decreased (346)
Myasthenia gravis (338)
What Other Drugs Cause Haemolysis?
ECULIZUMAB (1,476)
HUMAN IMMUNOGLOBULIN G (357)
RITUXIMAB (261)
PREDNISONE (192)
CYCLOSPORINE (173)
DEXAMETHASONE (167)
ACETAMINOPHEN (134)
VINCRISTINE (132)
TACROLIMUS (116)
CYCLOPHOSPHAMIDE (110)
Which RAVULIZUMAB-CWVZ Alternatives Have Lower Haemolysis Risk?
RAVULIZUMAB-CWVZ vs REBAMIPIDE
RAVULIZUMAB-CWVZ vs REBETOL
RAVULIZUMAB-CWVZ vs REBIF
RAVULIZUMAB-CWVZ vs REBOXETINE
RAVULIZUMAB-CWVZ vs RECLAST